Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize … – MarketWatch

PALATINE, IL, Jan 08, 2015 (Marketwired via COMTEX) — Acura Pharmaceuticals, Inc. ACUR, +0.00% today announced that the Company has entered into a Collaboration and License Agreement (the “Agreement”) with Egalet US, Inc. and Egalet Ltd. (together “Egalet”, subsidiaries of Egalet Corporation (NASDAQ: EGLT), which is also a party to the Agreement with obligations thereunder) granting Egalet exclusive worldwide rights to (more…)

Acura Pharmaceuticals Announces Update on AVERSION Products – MarketWatch (press release)

PALATINE, IL, Jul 27, 2012 (MARKETWIRE via COMTEX) — Acura Pharmaceuticals, Inc., a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today that Pfizer Inc. provided notice on July 26, 2012 that it is exercising its right to terminate the license to three development stage products using Acura’s AVERSION(R) Technology and return such products to Acura. (more…)